Utidelone Capsule (UTD2)

utidelone · Beijing Biostar Pharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Utidelone Capsule (UTD2), covering 2025-06-30 to 2025-06-30. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Clinical Study of Utidelone Capsule (UTD2) in Patients With Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]

See pricing